IDEAYA Biosciences Upcoming Investor Relations Events and Updated Darovasertib Topline Results Guidance from Phase 2/3 OptimUM-02 Trial

Go back to IDEAYA Biosciences Upcoming Investor Relations Events and Updated Darovasertib Topline Results Guidance from Phase 2/3 OptimUM-02 Trial
(NASDAQ: IDYA) Delayed: 34.23 +3.00 (9.61%)
Previous Close $31.23    52 Week High
Open $31.84    52 Week Low
Day High $34.48    P/E N/A 
Day Low $31.81    EPS
Volume 1,670,893